Safety and tolerability and quality of life Over the 2-year period, 222 (39%) individuals withdrew from the trial: 3443% of those randomized to liraglutide, and 40% of those randomized to placebo or orlistat
- Oral semaglutide (only FDA approved for diabetes treatment) and injectable liraglutide, (FDA approved for obesity treatment as Saxenda,) lead to relatively modest amount of weight loss
The Sourcing Checklist: Verifying Purity and COAs When evaluating a supplier, the gold standard for trust is independent, third-party analytical testing
(You can search the NIHR 'Be Part of Research' website, but always discuss eligibility with your clinician) What are the established treatment options that might better address my symptoms
GLP drugs belong to a class of medications known as GLP-1 receptor agonists
For some, iron may become an important consideration